Researchers developed a novel electrochemical biosensor technology capable of assessing symmetric dimethylarginine to detect early kidney disease, which could be adapted to detect other biomarkers for ...
The technology could allow clinicians to diagnose the disease at the point of care rather than wait for lab results. The study was published on November 14, 2024 in Biosensors and Bioelectronics.